Adrenomedullin (AM) and proadrenomedullin N-terminal 20 peptide (PAMP) are small peptides derived from a common precursor, pre-proadrenomedullin. Although AM and PAMP share hypotensive effects in the cardiovascular system, the peptides also exert diverse and distinct effects on endocrine physiology, innate immunity, cytoskeletal biology and receptor signaling pathways. Tremendous knowledge has been gleaned from the study of several genetic animal models of AM deletion or overexpression, some of which also simultaneously delete the coding region for PAMP peptide. However, deletion of PAMP without concurrent deletion of AM in an animal model is not currently available for the study of PAMP function. Here, we present the generation of Adm ΔPAMP/ΔPAMP and Adm ΔPAMP/− mice, which lack the coding sequence for PAMP while preserving the coding sequence for AM. Adm ΔPAMP/ΔPAMP mice survive to adulthood without any obvious abnormalities and are fertile, though Adm ΔPAMP/− females have small litters. Interestingly, these animals express lower levels of Adm mRNA and AM peptide than wild type animals, but these levels are still compatible with survival. Importantly, despite reduced levels, the spatiotemporal expression of AM peptide within the hearts of Adm ΔPAMP/− mice remains similar to wild type animals. Adm ΔPAMP/ΔPAMP mice are now a publicly available tool for future investigations of PAMP function.
Introduction
Proadrenomedullin N-terminal 20 peptide (PAMP) is a 20 amino acid byproduct of pre-proadrenomedullin, which is cleaved into signal peptide, PAMP, mid-regional proadrenomedullin (MR-proADM), and adrenomedullin (Adm, AM) [1] . AM is the best characterized of these byproducts due to the availability of animal models, and MR-proADM is gaining traction as a biomarker primarily of cardiovascular disease but also of pulmonary disease and pregnancy complications [2] [3] [4] . Far fewer studies have addressed the role of PAMP in physiology and pathophysiology.
Like AM, PAMP is potently expressed and secreted by adrenal chromaffin cells but is also found widely throughout the body, including in plasma and urine [5] . PAMP is hydrolyzed by neprilysin, and like other neprilysin targets, exerts a hypotensive effect [6] . For example, a bolus of human PAMP or PAMP [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] exerts a five to ten minute hypotensive effect in rats [7, 8] . In a hypertensive rat model, PAMP overexpression blunts blood pressure increases and lessens the severity of myocardial hypertrophy [9] . Evidence suggests that this PAMP hypotensive effect is secondary to inhibition of norepinephrine release from peripheral sympathetic nerves, due in part to a decrease in catecholamine synthesis enzyme expression [10] [11] [12] . A bona fide PAMP receptor remains elusive, but one study has suggested that PAMP activates the G-protein-coupled receptor MrgX2 via G αq and G αi [13] , while another study has suggested that the PAMP receptor is G αi3 -coupled [14] .
An assortment of biological roles for PAMP beyond blood pressure regulation have been identified. PAMP has been associated with https://doi.org/10.1016/j.peptides.2018.11.005 Received 8 August 2018; Received in revised form 19 November 2018; Accepted 25 November 2018 angiogenesis in humans, mice, chicken, and fish. It also possesses antimicrobial activity in humans [15] . PAMP is also anti-nicotinic and inhibits aldosterone secretion [16, 17] . More recently, a role for PAMP as a microtubule-associated protein has emerged. In this context, PAMP binds to tubulin, leading to its destabilization, and increases kinesin velocity [18, 19] .
A small body of literature has examined changes in plasma PAMP in several disease states in humans. Elevated plasma PAMP has been found in essential hypertension [20] , impaired renal function [21] , rheumatoid arthritis [22] , and congestive heart failure [23] , the severity of which correlates with PAMP levels [24] . In contrast, decreased plasma and urinary PAMP has been found in glomerulonephritis [25] .
Collectively, although several roles for PAMP have emerged since its discovery in the early 1990s, its primary biological function remains obscure. Moreover, it is still unknown whether PAMP is necessary for survival. In this regard, the more widely-studies protein product of preproadrenomedullin, AM peptide, is necessary for embryonic development and survival based on 3 independent genetic mouse models. One of these models exclusively deletes the coding sequence for AM peptide [26] , while two others delete the entire proadrenomedullin sequence and therefore both PAMP and AM peptides [27, 28] . Here, in a departure from previously published animal models, we present a novel gene targeting approach in which PAMP is deleted exclusively, while retaining the coding sequence for AM peptide, and demonstrate that mice lacking PAMP are viable and fertile.
Materials & methods

Generation of mice with deletion of PAMP coding sequence
Briefly, a gene targeting vector was generated containing the Adm promoter and exon 1, intron 1, part of exon 2, part of exon 3, intron 3, and exon 4 of the Adm gene upstream of a BamH1 site and a neomycin resistance cassette (Fig. 1A) . The targeting vector was electroporated into 129S6/SvEv embryonic stem cells, which were then subjected to neomycin selection. Homologous recombination in neomycin-resistant clones was confirmed by Southern blot after BamH1 digestion and/or PCR. Male chimeras were bred with wild type SvEv females to establish a genetically-pure, isogenic 129S6/SvEv line. PCR-based genotyping of the targeted allele was accomplished using two primers: P1 -5-GTGC TGACGGGATCGTGCTG-3′; P2 -5′-CATGCAGTACCCGAGGGACCT-3′. These primers amplify a 603 bp wild type allele and a 380 bp targeted allele ( animals [27] and Adm hi/hi animals [29] have been described elsewhere.
Gene expression analysis
Total RNA from Adm ΔPAMP/+ , Adm ΔPAMP/− and Adm
ΔPAMP/ΔPAMP
adult hearts was isolated with TRIzol. Complementary DNA (cDNA) was synthesized using M-MLV reverse transcriptase. For cDNA from wild type hearts, a commercially available stock of pooled wild type mouse heart cDNA was utilized. cDNA from all genotypes was then used in quantitative real-time reverse transcriptase PCR (qRT-PCR) on a Stratagene MXP3000 and MxPro Software (Stratagene). Mouse GAPDH was used as an endogenous reference gene. qRT-PCR was performed in biological triplicate or quadruplicate and in technical triplicate and analyzed using the 2 -ΔΔCt method.
Western blotting
Hearts from adult Adm +/+ , Adm ΔPAMP/ΔPAMP , and Adm hi/hi mice were homogenized and lysed. Lysate protein concentration was determined with a BCA Protein Assay Kit (Pierce). Protein was loaded onto a SDS-PAGE gel, subjected to gel electrophoresis, and then transferred to a nitrocellulose membrane. The membrane was blocked and probed overnight in anti-adrenomedullin antibody (Novus Biologicals) at 4°C. The membrane was washed in tris-buffered saline/0.1% Tween 20 (TBST), incubated in secondary antibody at room temperature, and then washed again in TBST. Finally, the blot was imaged on an Odyssey CLx (LI-COR).
Immunohistochemistry
Tissue sections were permeabilized, blocked with 5% normal donkey serum, and incubated overnight at room temperature with the primary antibody, rabbit anti-mouse adrenomedullin (1:100; Novus Biological), and then incubated with appropriate secondary antibody (1:200; Jackson ImmunoResearch Laboratories) and DAPI (1:1000; Sigma-Aldrich). Images were acquired on a Nikon E800 microscope (Nikon) with a Hamamatsu camera (Hamamatsu Photonics).
Results
To delete the coding sequence for PAMP, we generated a targeting vector that eliminated the PAMP-encoding 3′ region of exon 2 and the PAMP-encoding 5′ region of exon 3 as well as the interceding intron within the Adm gene locus (Fig. 1A) . Therefore, because exons 2 and 3 are genetically fused, the resulting targeted allele, Adm ΔPAMP , contains only 3 exons. In contrast to the 2 previously described AM knockout mouse models that concurrently delete PAMP, we discovered that Adm ΔPAMP/ΔPAMP animals survived to adulthood without any apparent abnormalities. We detected the targeted allele in adult heterozygous and homozygous mice by Southern blot (Fig. 1B) and by PCR (Fig. 1C) .
To confirm appropriate embryonic development and survival of Adm ΔPAMP/ΔPAMP animals, we determined the genotypes of 51 pups from 8 litters born to Adm ΔPAMP/+ intercrosses. The genotype ratios observed in our colony were consistent with the expected Mendelian ratios, as shown by an observed/expected ratio of approximately 1 for each genotype (Table 1) . Due to the unavailability of commercial antibodies for PAMP, we were unable to confirm the absence of PAMP protein expression as expected. Nevertheless, we assessed changes in Adm mRNA in wild type, heterozygous, and homozygous mice by qRT-PCR. We were surprised to find that Adm mRNA expression in hearts from Adm ΔPAMP/+ and Adm ΔPAMP/ΔPAMP mice was 76% and 50%, respectively, of Adm expression in wild type animals ( Fig. 2A) . To further confirm that the reduced expression of Adm mRNA originated from the Adm ΔPAMP allele, we crossed Adm ΔPAMP/+ mice to those with a full genetic knockout of the Adm locus, Adm +/− [27] , to generate a compound heterozygous mouse line, Adm ΔPAMP/-. Consistent with the expected genetic titration, these animals expressed approximately 2% of Adm mRNA, yet survived to adulthood, indicating that even a very low level of AM peptide is sufficient for embryonic survival. We observed a similar pattern of Adm mRNA expression in lungs from animals of these genotypes as well (data not shown).
Compared to wildtype animals, we confirmed the retained expression of AM peptide in Adm ΔPAMP/ΔPAMP homozygous animals (Fig. 2B) , indicating that the genetically engineered allele remained in frame for appropriate translation. Consistent with reduced mRNA expression levels, we observed a decrease in AM protein expression in hearts of Adm ΔPAMP/ΔPAMP homozygous animals by western blot (Fig. 2B ). This reduced expression stands in contrast to increased AM protein expression in hearts from Adm hi/hi mice, which overexpress AM via stabilization of the 5′ untranslated region of the Adm gene [29] . To confirm that the spatiotemporal regulatory expression of AM peptide was not altered by the AdmΔ PAMP allele, we performed immunohistochemistry for AM peptide in postnatal day 21 mouse hearts from an allelic genetic series of animals that have graded levels of AM expression. Fig. 2C shows that the expression of AM peptide is predictably localized in the epicardium (arrows) and endothelial cells of coronary vessels (arrowheads). Semi-quantitative staining intensity , similar to what has been previously reported for Adm +/-female mice [27] . Although PAMP peptide has been primarily characterized as a hypotensive factor [7, 8] , we failed to observe a statistically significant compensatory cardiac hypertrophy response in adult Adm
ΔPAMP/ΔPAMP
or Adm ΔPAMP/− animals, compared to wildtype animals, reflected by equivalent heart weight:body weight ratios, 4.76+/-0.32 mg/g (n = 4), 4.31+/−0.14 mg/g (N = 6), 4.12+/-0.14 mg/g (N = 7), respectively. These data imply that under basal conditions, there is unlikely to be a hypertensive phenotype in animals lacking PAMP.
Discussion
Here, we have described the generation of a genetically targeted mouse line in which portions of exon 2, exon 3 and intron 2 of the Adm gene are deleted, thereby eliminating the coding sequence for PAMP while preserving the coding sequence for AM peptide. We have also crossed this Adm ΔPAMP allele to a knockout allele of the Adm gene to generate a Adm ΔPAMP/− mouse line in which the expression of AM peptide only occurs from the Adm ΔPAMP allele. To our knowledge, this is the first genetic mouse model that deletes PAMP exclusively, in contrast to previously generated mouse models that delete AM and PAMP concurrently [27, 28] . Given that the genotypes of offspring from Adm ΔPAMP/+ intercrosses are born in expected Mendelian ratios and survive to adulthood, we conclude that Adm ΔPAMP/ΔPAMP mice are viable and without any apparent developmental abnormalities. Once Adm ΔPAMP/ΔPAMP mice reach adulthood, they are fertile and can therefore be intercrossed. Thus, in contrast to the essential functions of AM peptide in mammalian embryogenesis and fertility, PAMP peptide is dispensable.
The lack of commercial antibodies for PAMP precludes our ability to directly confirm deletion of PAMP by traditional western blot analysis. However, we assessed changes in Adm mRNA and protein by qRT-PCR, western blotting and immunohistochemistry, which consistently demonstrated a positive correlation between PAMP genotype and AM dosage in the heart. Interestingly, AM expression in the heart of Adm ΔPAMP/ΔPAMP animals was approximately 50% of that of wild-type animals, suggesting that there may exist intronic regulatory elements within deleted intron 2 of the Adm gene, or as yet unidentified epigenetic control mechanisms, which may control the overall mRNA transcription. Nevertheless, this reduction in AM expression did not impair embryonic development. Therefore, in light of these findings and the embryonic lethality of Adm −/− embryos by e12.5, we conclude that a very small dosage of AM peptide is sufficient for ensuring survival. We previously showed that genetic titration of Adm does not affect basal blood pressure [30] . Therefore, we do not expect basal blood pressure to change with alterations in PAMP expression, especially given that the PAMP hypotensive effect appears to be less potent than the AM hypotensive effect. Consistent with this rationale, we observed no compensatory cardiac hypertrophy in Adm 
